Immucell Corp. (ICCC)
NASDAQ:ICCC
Holding ICCC?
Track your performance easily

Immucell (ICCC) Stock Price & Analysis

70 Followers

ICCC Stock Chart & Stats


Financials

Annual

Ownership Overview

1.76%4.10%0.50%90.44%
1.76%
Insiders
0.50% Other Institutional Investors
90.44% Public Companies and
Individual Investors

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

ICCC FAQ

What was Immucell Corp.’s price range in the past 12 months?
Immucell Corp. lowest stock price was $3.34 and its highest was $5.59 in the past 12 months.
    What is Immucell Corp.’s market cap?
    Currently, no data Available
    When is Immucell Corp.’s upcoming earnings report date?
    Immucell Corp.’s upcoming earnings report date is Nov 13, 2024 which is in 8 days.
      How were Immucell Corp.’s earnings last quarter?
      Immucell Corp. released its earnings results on Aug 13, 2024. The company reported -$0.196 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.196.
        Is Immucell Corp. overvalued?
        According to Wall Street analysts Immucell Corp.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Immucell Corp. pay dividends?
          Immucell Corp. does not currently pay dividends.
          What is Immucell Corp.’s EPS estimate?
          Immucell Corp.’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Immucell Corp. have?
          Immucell Corp. has 7,833,080 shares outstanding.
            What happened to Immucell Corp.’s price movement after its last earnings report?
            Immucell Corp. reported an EPS of -$0.196 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -4.255%.
              Which hedge fund is a major shareholder of Immucell Corp.?
              Currently, no hedge funds are holding shares in ICCC
              ---

              Immucell Stock Smart Score

              10
              Unlock Smart Score
              1
              2
              3
              4
              5
              6
              7
              8
              9
              10

              Technicals

              SMA
              Negative
              20 days / 200 days
              Momentum
              -29.80%
              12-Months-Change

              Fundamentals

              Return on Equity
              -16.10%
              Trailing 12-Months
              Asset Growth
              -4.89%
              Trailing 12-Months

              Company Description

              Immucell Corp.

              ImmuCell Corp. engages in the development, acquisition, manufacture and sale of products that improve the health and productivity of cows for the dairy and beef industries. Its products include first defense for scours, California mastitis test kit and purified nisin intramammary treatment for mastitis. The company was founded in 1982 and is headquartered in Portland, ME.
              ---

              ICCC Company Deck

              ---

              ICCC Earnings Call

              Q2 2024
              0:00 / 0:00
              ---
              Similar Stocks
              Company
              Price & Change
              Follow
              Applied DNA Sciences
              BioNano Genomics
              Karyopharm Therapeutics
              Rigel
              Popular Stocks
              ---
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis